BD Receives U.S. FDA Approval for First Venous Stent to Treat Iliofemoral Venous Occlusive Disease
Venovo Venous Stent proven safe and effective in iliac and femoral veins
FRANKLIN LAKES, N.J., March 14, 2019 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, tod... Devices, Interventional, FDA BD , Venovo, venous stent, venous occlusive disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Marketing | Pharmaceuticals